name,pdb_id,pubmed_id,resolution,uniprot,PFAM,CATH,receptor_chain,receptor_length,peptide_chain,peptide_length,sequence_alignment,stride,percent_exposed_alignment,cluster_number,binding_mode,size_of_binding_mode,core_ecr_alignment,longest_continuous_core,longest_continuous_ecr,corebinding_aa,exosite_aa,surface_aa,interior_aa,corebinding_ss,exosite_ss,surface_ss,interior_ss,unique_id,COREBINDING_aa,COREBINDING_ss,EXOSITE_aa,EXOSITE_ss,bfact,bs_loc_type,full_peptide_sequece,mean_seq_iden_in_bm,mean_seq_iden_not_bm,min_dist_E_C_diff_bm,occupancy,pep_loc_type,title
2XZQ_L_P_222_2.pdb,2XZQ,22266283,2.40,,,2.60.40.10,L,211,P,9,YQLRPNAET,CCCCCCCCC,301211431,222,2,1,CCCCCCCCC,9,0,A:0;H:0;N:0;S:0;T:0;W:0;Y:0,A:0;H:0;N:0;S:0;T:0;W:0;Y:0,A:1;D:1;E:6;F:1;G:6;H:2;K:2;L:1;N:2;P:3;Q:3;R:2;S:6;T:3,A:12;C:4;D:5;E:7;F:5;G:13;H:2;I:5;K:6;L:14;M:2;N:4;P:8;Q:7;R:4;S:14;T:24;V:16;W:3;Y:5,C:0;E:0;G:0;T:0,C:0;E:0;G:0;T:0,C:5;E:11;G:2;H:5;T:16,B:2;C:21;E:104;G:2;H:6;T:23;b:2,222_2,A:1;H:1;N:2;S:2;T:2;W:2;Y:2,C:2;E:4;G:2;T:4,A:0;H:0;N:0;S:0;T:0;W:0;Y:0,C:0;E:0;G:0;T:0,999999999,ALA_2_L_COREBINDING;ASN_33_L_COREBINDING;ASN_96_L_COREBINDING;HIS_97_L_COREBINDING;SER_32_L_COREBINDING;SER_95_L_COREBINDING;THR_26_L_COREBINDING;THR_30_L_COREBINDING;TRP_93_L_COREBINDING;TRP_98_L_COREBINDING;TYR_34_L_COREBINDING;TYR_94_L_COREBINDING,YQLRPNAETLRF,-1,0.246753246753247,,999999999,TYR_1_P_C;GLN_2_P_C;LEU_3_P_C;ARG_4_P_C;PRO_5_P_C;ASN_6_P_C;ALA_7_P_C;GLU_8_P_C;THR_9_P_C,"CRYSTAL STRUCTURE ANALYSIS OF THE ANTI4HYDROXY3 2 NITROPHENYLACETYL MURINE GERMLINE MONOCLONAL ANTIBODY 3 BBE612H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY 4 DERIVED DODECAPEPTIDE YQLRPNAETLRF"
4NRX_H_P_222_1.pdb,4NRX,24335316,2.21,,,2.60.40.10,H,231,P,14,NEQELLELDKWASL,TTTGGGGGTTTTCC,34211010011023,222,1,1,CCCCCCCCCCCCCC,14,0,A:0;D:0;E:0;F:0;H:0;I:0;K:0;R:0;S:0;T:0;W:0;Y:0,A:0;D:0;E:0;F:0;H:0;I:0;K:0;R:0;S:0;T:0;W:0;Y:0,A:2;E:1;G:7;H:1;K:9;L:1;N:1;P:4;Q:4;S:15;T:3;Y:1,A:12;C:4;D:5;E:4;F:5;G:14;H:1;I:8;K:6;L:12;M:3;N:6;P:9;Q:7;R:2;S:18;T:13;V:21;W:5;Y:9,C:0;E:0;T:0,C:0;E:0;T:0,B:1;C:15;E:7;G:4;T:22,B:3;C:23;E:105;G:8;T:23;b:2,222_1,A:1;D:2;E:1;F:1;H:1;I:1;K:1;R:1;S:2;T:1;W:1;Y:5,C:5;E:6;T:7,A:0;D:0;E:0;F:0;H:0;I:0;K:0;R:0;S:0;T:0;W:0;Y:0,C:0;E:0;T:0,66554343334456,ALA_112_H_COREBINDING;ARG_110_H_COREBINDING;ASP_55_H_COREBINDING;ASP_57_H_COREBINDING;GLU_32_H_COREBINDING;HIS_101_H_COREBINDING;ILE_50_H_COREBINDING;LYS_59_H_COREBINDING;PHE_108_H_COREBINDING;SER_106_H_COREBINDING;SER_31_H_COREBINDING;THR_111_H_COREBINDING;TRP_33_H_COREBINDING;TYR_107_H_COREBINDING;TYR_109_H_COREBINDING;TYR_113_H_COREBINDING;TYR_115_H_COREBINDING;TYR_52_H_COREBINDING,NQQKRNEQELLELDKWASL,-1,0.246753246753247,,99999999999999,ASN_1_P_C;GLU_2_P_C;GLN_3_P_C;GLU_4_P_C;LEU_5_P_C;LEU_6_P_C;GLU_7_P_C;LEU_8_P_C;ASP_9_P_C;LYS_10_P_C;TRP_11_P_C;ALA_12_P_C;SER_13_P_C;LEU_14_P_C,"CRYSTAL STRUCTURE OF HIV1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH 2 GP41 MPER PEPTIDE"
